Aphelion Capital has partnered with the American Heart Association, UPMC Enterprises, and Philips to form Cardeation Capital. Cardeation is a venture fund formed to invest in innovative healthcare products, services, and technologies that align with the mission of the American Heart Association. As partners, we work collaboratively to aid thoughtful entrepreneurs and their companies to attain commercial success and ultimately drive better outcomes and reduced costs in our healthcare system.

Our Partners​

The American Heart Association is devoted to saving people from heart disease and stroke — the two leading causes of death in the world. We team with millions of volunteers to fund innovative research, fight for stronger public health policies, and provide lifesaving tools and information to prevent and treat these diseases. The Dallas-based association is the nation’s oldest and largest voluntary organization dedicated to fighting heart disease and stroke.

At Philips, we look beyond technology to the experiences of consumers, patients, providers and caregivers across the health continuum – from healthy living and prevention to diagnosis, treatment and home care. We unlock insights leading to innovative solutions that enable better care at lower cost. With leading research, design and innovation capabilities, we partner with our customers to transform the delivery of healthcare.
 

​​
Working with its world-renowned clinicians at the UPMC Heart and Vascular Institute, UPMC Enterprises aims to accelerate heart-related innovations that will improve the lives of its patients and others around the world, while providing returns that can be reinvested into its care and research missions.
Cardeation Deal Submission